AMM ads promote power of journals

Share this article:
The Association of Medical Media, together with the American Business Media, has launched an ad campaign it hopes will help ease sharp cutbacks in primary care journal advertising.

The “Mean Streets” campaign, executed by Regan Campbell Ward • McCann under the direction of AMM consultant Will Passano, emphasizes that journal ads and detailing work together.
The advertisements, appearing in trade magazines (including MM&M), show an illustration of a sales representative, surrounded by anthropomorphic, boxing-gloved journals, and the copy: “Today's office can be hard on reps. Don't send them in there without journal advertising.”
 The titles of the journals pictured in the ads will rotate over the course of the campaign, which will likely run for a year.

“We came up with the concept that advertising works in concert with the detail force,” said Passano, president of Ascend Media Healthcare. “We hope to bring more attention to the fact that detailing and advertising are a nice complement.”

Passano notes that journals reach healthcare professionals in many places that reps don't, like hospitals, and that companies need not worry about consistency of message with ads as they do with reps. “Advertising copy is always controlled and on message,” he said.

Medical publishers have suffered so far in 2007, with page counts for many of the top primary care titles off around 25% for the first half over the same period last year.

The downswing is being fueled by the continuing dearth of big new product launches, as well as the longer-term migration of spending away from journal ads and into other media.

The Association of Medical Publications recently rebranded as the AMM in recognition of medical advertising agencies, one of its chief constituents.   

Share this article:
You must be a registered member of MMM to post a comment.


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...